Updates in MS research from ACTRIMS 2026: trial updates, new technologies, & more
This episode focuses on key updates in multiple sclerosis (MS) research from the 11th Annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum. We begin with key trial updates, including the FENtrepid (NCT04544449) and MoonStone (NCT06564311) results presented by Amit Bar-Or, MD, FRCPC, University of Pennsylvania, Philadelphia, PA. Le Hanh Hua, MD, Cleveland Clinic, Las Vegas, NV, then discusses a secondary analysis of the OLIKOS study (NCT04486716), and Jeffrey Cohen, MD, Cleveland Clinic, Cleveland, OH, introduces the use of hematopoietic stem cell…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.